Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06277752
Status:
COMPLETED
Last Update Posted:
2024-03-22
First Post:
2024-02-04
Brief Title:
A Study to Investigate the PharmacokineticPharmacodynamic Characteristics of IBI128A New Xanthine Oxidase Inhibitor
Sponsor:
Innovent Biologics Suzhou Co Ltd
Organization:
Innovent Biologics Suzhou Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-04
First Submit QC Date:
February 19 2024
Study First Post Date:
2024-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-20
Last Update Post Date:
2024-03-22
Last Update Post Date Type:
ACTUAL